The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease

Neurobiology of Aging

Volumn 23, Issue 3, 2002, Pages 383-388

  Selley, M L ^a,c,d   Close, D R ^a   Stern, S E ^b  

^a Angiogen Pharmaceuticals Pty Ltd   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c Biology and Environment   (Australia)

^d NONE   (Australia)

Author keywords

(E) 4 Hydroxy 2 nonenal; Alzheimer's disease; Cerebrospinal fluid; Homocysteine; Lipid peroxidation; Plasma; Vitamin B12

Indexed keywords

4 HYDROXYNONENAL; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CEREBROSPINAL FLUID EXAMINATION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALDEHYDES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; DRUG INTERACTIONS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; STATISTICS, NONPARAMETRIC; VITAMIN B 12;

EID: 0036224435     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00327-X     Document Type: Article

References (48)

1. 12, and serum total homocysteine levels in confirmed Alzheimer's disease
2. Hyperhomocysteinemia. A new risk factor for Alzheimer's disease?
3. Total serum homocysteine in senile dementia of Alzheimer type
4. Homocysteine and Alzheimer's disease
5. Serum folate and the severity of atrophy of the neocortex in Alzheimer's disease: Findings from the Nun study
6. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
7. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
8. Oxidative alterations in Alzheimer's disease
9. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
10. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease
11. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
12. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
13. 4-Hydoxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
14. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
15. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis, and neuronal death by amyloid beta-peptide
16. Impairment of glucose and glutamate transport and induction of mitochondial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal
17. Amyloid β-peptide impairs glucose transport in hippocampal, and cortical neurons: Involvement of membrane lipid peroxidation
18. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes
19. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine, and metabotropic glutamate receptors: Possible action on G alpha (q/11)
20. The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells
21. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons, and impairs visuospatial memory in rats
22. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease
23. 4-Hydroxy-2-(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites
24. Mitochondrial involvement in Alzheimer's disease
25. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
26. 4-Hydroxynonenal increases neuronal susceptibility to oxidative stress
27. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of beta I and beta II PKCs in NT2 cells
28. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau
29. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubles, and modifies cellular tubulin
30. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats
31. Cobalt-vitamin B12 deficiency causes lipid accumulation, lipid peroxidation, and decreased alpha-tocopherol concentrations in the liver of sheep
32. Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs
33. Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading
34. Enhanced in vivo lipid peroxidation at elevated plasma homocysteine levels
35. Oxidative stress in the context of acute cerebrovascular stroke
36. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation
37. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association) Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
38. "Mini-mental state." A practical method for grading the cognitive status of patients for the clinician
39. A new rating scale for Alzheimer's disease
40. Quantitation of total homocysteine, total cysteine, and methionine in normal serum, and urine using capillary gas chromatography-mass spectrometry
41. Determination of the lipid peroxidation product (E)-4-hydroxy-2-nonenal in clinical samples by gas chromatography-negative-ion chemical ionisation mass spectrometry of the O-pentaflurobenzyl oxime
42. (E)-4-Hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease
43. Increased lipoprotein oxidation in Alzheimer's disease
44. 4-Hydroxy-2-nonenal-trapping ELISA: Direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins
45. Oxidation of low density lipoprotein by thiols: Superoxide-dependent and -independent mechanisms
46. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol
47. The role of metals in neurodegenerative diseases